Novartis India
BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 | Pharmaceuticals
 |
 |
Yearly Results of Novartis India |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| Sales Turnover | 471.49 | 525.92 | 542.24 | 553.45 | 613.51 | |||||
| Other Income | 39.38 | 66.01 | 50.08 | 58.94 | 51.96 | |||||
| Total Income | 510.87 | 591.93 | 592.32 | 612.39 | 665.47 | |||||
| Total Expenses | 400.86 | 439.77 | 453.67 | 454.63 | 489.16 | |||||
| Operating Profit | 70.63 | 86.15 | 88.57 | 98.82 | 124.35 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 110.01 | 152.16 | 138.65 | 157.76 | 176.31 | |||||
| Interest | 0.75 | 2.65 | 0.63 | 0.60 | 0.71 | |||||
| PBDT | 109.26 | 149.51 | 138.02 | 157.16 | 175.60 | |||||
| Depreciation | 5.22 | 0.59 | 2.67 | 2.85 | 2.69 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 104.04 | 148.92 | 135.35 | 154.31 | 172.91 | |||||
| Tax | 38.92 | 41.03 | 46.80 | 57.08 | 69.20 | |||||
| Net Profit | 65.12 | 107.89 | 88.55 | 97.23 | 103.71 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 20.38 | 33.76 | 27.71 | 30.42 | 32.45 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 15.98 | 15.98 | 15.98 | 15.98 | 15.98 | |||||
| Reserves | 268.39 | 321.62 | 372.60 | -- | 498.76 | |||||
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Novartis India connections | ||||||||||
| ||||||||||
